Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chele Chiavacci Farley Insider Profile
4 Followers
Chele Chiavacci Farley, Director at Conduit Pharmaceuticals, holds 52.27K shares in Conduit Pharmaceuticals (Ticker: CDT).
Chele Chiavacci Farley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Chele Chiavacci Farley's holdings
Insider Roles
Director
Roles that Chele Chiavacci Farley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Chele Chiavacci Farley
Chele Chiavacci Farley's Trading History
List of latest transactions for each holding click on a transaction to see Chele Chiavacci Farley's performance on stock
You May Also Like
Chele Chiavacci Farley insider profile FAQ
What is the percentage of profitable transactions made by Chele Chiavacci Farley?
The percentage of profitable transactions made by Chele Chiavacci Farley is ―.
What is the average return per transaction made by Chele Chiavacci Farley?
The average return per transaction made by Chele Chiavacci Farley is ―.
What stocks does Chele Chiavacci Farley hold?
Chele Chiavacci Farley holds: CDT stocks.
What was Chele Chiavacci Farley’s latest transaction?
Chele Chiavacci Farley latest transaction was an Uninformative Buy of ―.
What was Chele Chiavacci Farley's most profitable transaction?
Chele Chiavacci Farley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Chele Chiavacci Farley's role in Conduit Pharmaceuticals?
Chele Chiavacci Farley's role in Conduit Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.